Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of microcapsule powder and filler, which is applied in the field of health care products, can solve problems such as single effect and difficulty in meeting multiple needs of users, and achieve good health care effects, prevent cerebral hemorrhage, and reduce blood lipids
Inactive Publication Date: 2017-12-22
张家港中宝生物技术有限公司
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] There are various microencapsulated powders available, such as linseed oil microencapsulated powder, oatmeal microencapsulated powd
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0016] The present invention provides a kind of microcapsule powder, and described microcapsule powder is made up of the following components by weight: 3-5 parts of soybean lecithin, 20-30 parts of filler, 3-5 parts of emulsifier, chitosan 2-3 parts, 1-2 parts of krill oil, 40-50 parts of water; the particle size of the microcapsule powder is 1-100 mesh.
[0017] The microcapsule powder has the effect of health care, and soybean lecithin has the effects of emulsification, wetting and dispersion, and can promote fat metabolism in the body, muscle growth, nervous system development and anti-oxidative damage in the body; chitosan has the functions of improving immunity, Activate cells, prevent cancer, lower blood fat, lower blood pressure, anti-aging, and regulate the body's environment; krill oil has the effect of lowering blood fat, cholesterol, preventing cerebral hemorrhage, cerebral thrombosis, reducing blood viscosity, promoting blood circulation, and preventing high blood ...
Embodiment 2
[0021] As a preferred embodiment of the present invention, the microcapsule powder is composed of the following components by weight: 3 parts of soybean lecithin, 20 parts of filler, 3 parts of emulsifier, 2 parts of chitosan, 1 part of krill oil part, 45 parts of water; the particle diameter of the microcapsule powder is 1-100 mesh.
Embodiment 3
[0023] As a preferred embodiment of the present invention, the microcapsule powder is composed of the following components by weight: 4 parts of soybean lecithin, 25 parts of filler, 4 parts of emulsifier, 3 parts of chitosan, 2 parts of krill oil part, 50 parts of water; the particle diameter of the microcapsule powder is 1-100 mesh.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Particle size
aaaaa
aaaaa
Login to view more
Abstract
The invention provides micro-capsule powder. The micro-capsule powder is prepared from the following components in parts by weight: 3-5 parts of soybean lecithin, 20-30 parts of a filling agent, 3-5 parts of an emulsifying agent, 2-3 parts of chitosan, 1-2 parts of krill oil and 40-50 parts of water. The particle size of the micro-capsule powder is 1-100-mesh. The soybean lecithin has the functions of emulsifying, moistening and dispersing and has the effects of promoting fat metabolism in the body, muscle growth, nervous system development and anti-oxidative damage in the body; the chitosan has the effects of improving immunity, activating cells, preventing cancers, reducing blood fat, reducing blood pressure, resisting ageing and adjusting the body environment; and the krill oil has the effects of reducing blood fat and cholesterol, preventing cerebral hemorrhage and cerebral thrombosis, reducing blood viscosity and promoting blood circulation, can be conveniently absorbed by the human body, and has better health care effects. The micro-capsule powder can also contain beta-carotenes, astaxanthin, vitamin C palmitate and L-carnitine, so that the micro-capsule powder has multiple effects and can meet multiple demands of people.
Description
technical field [0001] The invention relates to the technical field of health care products, in particular to a microcapsule powder. Background technique [0002] Microcapsule embedding technology refers to the technology of using natural or synthetic polymer film-forming materials to embed solids, liquids or gases to form tiny capsules with a diameter of several microns to hundreds of microns. Microcapsule embedding technology originated in the 1950s. After decades of continuous development, microcapsule embedding technology has become increasingly mature and is widely used in medicine, food, health care products and other fields. Microcapsule embedding technology has the following advantages: (1) protect the core material from external factors; (2) the core material is not damaged by gastric acid, directly reaches the small intestine, and has a higher absorption rate; (4) It can realize the slow and controlled release of the core material, so that the original performance...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more